An observational study in Education Nursing, Communication Skills and Ethics Education, sponsored by University of Padova. Not yet recruiting. Per ClinicalTrials.gov, last updated 2026-10-06.
Sponsored by University of Padova · Observational
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Effective communication in healthcare is vital for patient satisfaction, safety, outcomes, and ethical practice, supporting shared decision-making and informed consent. Simulation-based training is widely used to strengthen communication skills and foster empathy through emotionally engaging experiences.
This is a pilot study aimed (1) to assess changes in emotional state and empathy in nursing students after a simulation-based workshop (SBW) on delivering bad news, and (2) to evaluate the sensitivity of standardized scales in detecting these changes.
This observational, longitudinal, descriptive study will be conducted among advanced nursing students participating in a six-hour Simulation-Based Workshop (SBW) comprising three sessions. In Session 1, students will discuss the SPIKES protocol for communicating bad news and analyze a clinical case. Baseline affective states will be assessed using the Positive and Negative Affect Schedule (PANAS). In Session 2, students will participate in role-plays with simulated patients (SPs). Immediately following the role-plays, students will record their emotional reflections (ER) and complete the Jefferson Scale of Empathy for Health Professionals (JSE-HP), the Jefferson Scale of Patient Perceptions of Physician Empathy (JSPPPE), adapted to assess healthcare professional communication, and the PANAS. Instructors and SPs will also complete the adapted JSPPPE to evaluate students' empathic communication. In Session 3, students will participate in a structured debriefing, after which ER, JSE-HP, and JSPPPE will be reassessed.
The PANAS will be used to assess affective states through 20 items comprising 10 positive-affect (PA) and 10 negative-affect (NA) items. Higher PA scores will indicate greater levels of enthusiasm and motivation, whereas lower scores will reflect reduced energy and sadness. Higher NA scores will indicate greater negative affect, including feelings of anger and disgust, while lower scores will reflect calmer and more serene emotional states.
The JSE-HP will be used to assess empathy in healthcare professionals, particularly their ability to understand and communicate patients' perspectives. The instrument comprises 20 items rated on a 7-point Likert scale, yielding total scores ranging from 20 to 140, with higher scores indicating a greater empathic orientation.
The JSPPPE will be used to assess perceptions of healthcare professionals' empathic communication. The five-item instrument will be rated on a 7-point Likert scale and will assess dimensions including understanding, concern, and perspective-taking. Total scores will range from 5 to 35, with higher scores indicating greater perceived empathy.
720 studies on the registry are indexed under Communication; 160 are open to participants now.
This study's planned enrollment of 10 is below the median of 104 across 132 observational studies indexed under Communication.
Browse Communication studies →University of Padova is the lead sponsor of 215 studies on the registry; 39 are open to participants now.
Counted across the registry records on this site, refreshed daily.
The criteria were revised on the registry on Oct 6, 2026. See what changed
Advanced students from nursing or other healthcare professions who conduct a simulation-based workshop as part of their communication training curriculum.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Changes of emotions after the simulation-based workshop on communication of bad news
Questionnaires from the PANAS will be completed by the participants.
Time frame: PANAS scores will be assessed at three time points: after Session 1 (baseline; Day 0), Session 2 (simulation; Day 7), and Session 3 (debriefing; Day 14), scheduled for April 1 (Day 0), 8 (session 2), and 15 (session 3), 2027, respectively.
Changes of empathy during a simulation-based workshop on communication of bad news measured by Jefferson Scale of Empathy.
Participants will assess changes in their conceptualizations of empathy by completing the Health Professions Version of the Jefferson Scale of Empathy (JSE-HP).
Time frame: Students will complete the JSE-HP questionnaire after sessions two (S2) and three (S3) of the three-stage, simulation-based workshop on communicating bad news. S2 is planed to take place on April 8, 2027, and S3 on April 15, 2027.
Changes of perceived empathy after participating in a simulation-based workshop on communication of bad news measured by Jefferson Scale of Patient Perceptions of Physician Empathy
Self-perceived empathy will be scored during the communication of bad news using the Jefferson Scale of Patient Perceptions of Physician Empathy (JSPPPE).
Time frame: Complete the JSPPPE after sessions two and three, or the simulation and debriefing days (April 8 and 15, 2027 respectively), of the three-stage, simulation-based workshop on communicating bad news.
Changes in self-perceived emotions while executing the simulation-based workshop on communication of bad news
Participants will record their self-perceived emotions (emotional reflections) by writing about their feelings, emotions, and sensations in a logbook.
Time frame: Records will be taken after Session 2 (Simulation Day, April 8, 2027) and Session 3 (Debriefing Day, April 15, 2027).
No study locations are listed for this record.
Start is estimated for Apr 2027; primary completion for Aug 2027, 4 months later.
Of 51 non-industry observational studies under Communication, half reached primary completion within 25 months of starting (the median), counting those still running; a quarter within 10 and three quarters within 61. This study's planned 4 months is below that.
Counting every sponsor, half of 53 studies reached it within 25 months; a quarter within 9 and three quarters within 61.
Since we started tracking on Sep 25, 2026, the dates moved once, on Oct 6, 2026: start Aug 2025 → Apr 2027, primary completion Aug 2025 → Aug 2027 and completion Aug 2026 → Aug 2027.
Earlier changes are on the record history on ClinicalTrials.gov ↗
How these figures are worked out, and which studies are left out of them.
From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗
This study is not yet recruiting, as verified in Sep 2026. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.